Press release
Deadline on Feb. 6th coming up in Lawsuit for Investors in Veru Inc. (NASDAQ: VERU)
A Deadline is coming up on February 6, 2023 in the lawsuit for certain investors in Veru Inc. (NASDAQ: VERU).
Investors who purchased shares of Veru Inc. (NASDAQ: VERU) have certain options and there are strict and short deadlines running. Deadline: February 6, 2023. NASDAQ: VERU stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed in the U.S. District Court for the Southern District of Florida the plaintiff alleges on behalf of purchasers of Veru Inc. (NASDAQ: VERU) common shares between May 11, 2022 and November 9, 2022, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between May 11, 2022 and November 9, 2022, the Defendants made false and/or misleading statements, as well as failed to disclose material adverse facts about the data from the VERU-111 Phase 3 trial and the Company's interactions with the FDA, that Veru Inc. misled its shareholders to believe that the data from the Phase 3 trial was sufficient to support Emergency Use Authorization ("EUA") and even the submission of a New Drug Application ("NDA") without any further studies, and that VERU's filings therefore concealed the true risks faced by the Company in gaining approval for its EUA request.
Those who purchased shares of Veru Inc. (NASDAQ: VERU) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Deadline on Feb. 6th coming up in Lawsuit for Investors in Veru Inc. (NASDAQ: VERU) here
News-ID: 2905447 • Views: …
More Releases from Shareholders Foundation
Lawsuit for Investors in Sonder Holdings Inc. (NASDAQ: SOND) filed in effort to …
An investor, who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND), filed a lawsuit over alleged violations of Federal Securities Laws by Sonder Holdings Inc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: SOND investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
Lawsuit filed for Investors in Ocugen, Inc. (NASDAQ: OCGN) in effort to recover …
An investor, who purchased shares of Ocugen, Inc. (NASDAQ: OCGN), filed a lawsuit i over alleged violations of Federal Securities Laws by Ocugen, Inc..
Investors who purchased shares of Ocugen, Inc. (NASDAQ: OCGN) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: OCGN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Malvern, PA based Ocugen, Inc., a…
Investors who lost money with shares of Evolv Technologies Holdings, Inc. (NASDA …
An investor, who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV), filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged violations of Federal Securities Laws by Evolv Technologies Holdings, Inc. f/k/a NewHold Investment Corp.
Investors who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) have certain options and for certain investors are short and strict deadlines running. Deadline: May 24, 2024. NASDAQ: EVLV…
Investigation announced for Investors who purchased shares of Comtech Telecommun …
Comtech Telecommunications Corp is under investigation over potential securities laws violations in connection with certain financial statements.
Investors who purchased shares of Comtech Telecommunications Corp. (NASDAQ: CMTL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Comtech Telecommunications Corp. regarding its business, its prospects and its operations were materially false…
More Releases for VERU
GnRH Receptor Antagonists Market Insights Covering Growing Market Dynamics and C …
Global GnRH Receptor Antagonists Market Research Report provides key analysis of the market status of the GnRH Receptor Antagonists with the best facts and figures, meaning, definition, SWOT analysis, expert opinions, and the latest developments across the globe. The report also calculates the market size, Sales, Price, Revenue, Gross Margin, Market Share, cost structure, and growth rate. The report considers the revenue generated from the sales of this Report and…
Female Health Market Key Country Analysis | Veru Inc., Allergan, Bayer AG, Merck …
Female Health Market research report gives the best answers to many of the critical business questions and challenges. Additionally, the data, facts, and figures gathered to produce this market report are obtained from trustworthy sources such as websites, journals, mergers, newspapers, and other authentic sources. The report has a wide scope that includes market scenarios, comparative pricing between major players, cost and profit of the specified market regions. To implement…
Androgen Deprivation Therapy (ADT) Market Size 2022-2028 | Pfizer, Astellas Phar …
The Androgen Deprivation Therapy (ADT) Market research report contains a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies interspersed with relevant data. Furthermore, the report offers an up-to-date analysis of the current market scenario, the latest trends and drivers, and the overall market environment. It also examines market…
(Post-pandemic Era) Female Health Management Market to Witness Huge Growth by Ke …
Female Health Management Market Forecasts report provided to identify significant trends, drivers, influence factors in global and regions, agreements, new product launches and acquisitions, Analysis, market drivers, opportunities and challenges, risks in the market, cost and forecasts to 2027.
Get Free Sample PDF (including full TOC, Tables and Figures) of Female Health Management Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4671380
The report provides a comprehensive analysis of company profiles listed below:
- Veru Inc.
- Teva Pharmaceuticals
-…
Contraceptive Devices Market to Reflect Steadfast Expansion During 2021-2028 | G …
Overview of Global Contraceptive Devices Market:
Contraceptive Devices Market research report has been created with the systematic gathering and evaluation of Market information for Healthcare industry which is presented in a form that explains various facts and figures to the business. This Market survey document contains thorough analysis of Market and numerous related factors that range from Market drivers, Market restraints, Market segmentation, opportunities, challenges, and Market revenues to competitive analysis.…
Androgen Deprivation Therapy Market with Key Players like Allergan, Amgen, Astel …
An off-the-shelf report on Androgen Deprivation Therapy Market which has been compiled after an in-depth analysis of the market trends prevailing across five geographies (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). Various segments of the market such as type/components/ application/industry verticals/ end-users are analyzed with robust research methodology which includes three step process starting with extensive secondary research to gather data from company profiles, global/regional associations, trade…
